| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.9M | +8.0% | +3.5% |
| Cost of Revenue | $1.6M | -47.4% | -45.7% |
| Gross Profit | $4.2M | +82.4% | +59.2% |
| R&D Expense | $0 | — | — |
| SG&A Expense | $3.2M | +50.8% | +17.4% |
| Operating Income | $639K | +487.3% | +222.0% |
| Pre-tax Income | $735K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $17.6M | -32.8% | -37.1% |
| Accounts Receivable | $306K | +236.8% | +936.9% |
| Current Assets | $24.1M | -43.6% | -35.9% |
| Total Assets | $32.1M | -32.4% | -25.7% |
| Current Liabilities | $22.7M | -25.4% | -21.7% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.7M | — | — |
| Investing Cash Flow | $1.1M | — | — |
| Financing Cash Flow | -$5.3M | — | — |
| +213.2% |
| Net Income | $655K | +254.7% | +200.9% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| $23.6M |
| -24.4% |
| -20.1% |
| Stockholders' Equity | $8.4M | -48.2% | -38.6% |